BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35707983)

  • 1. Histamine H2 receptor antagonist exposure was related to decreased all-cause mortality in critical ill patients with heart failure: a cohort study.
    Huang YH; Cai WK; Yin SJ; Wang P; Li ZR; Yang Q; Zhou T; Meng R; Yang M; Guo Y; He GH
    Eur J Prev Cardiol; 2022 Oct; 29(14):1854-1865. PubMed ID: 35707983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histamine H2 receptor antagonist exhibited comparable all-cause mortality-decreasing effect as β-blockers in critically ill patients with heart failure: a cohort study.
    Zhang XS; Cai WK; Wang P; Xu R; Yin SJ; Huang YH; Guo Y; Jiang FF; Pan JM; Li YH; He GH
    Front Pharmacol; 2023; 14():1273640. PubMed ID: 38035020
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of Histamine H2 Receptor Antagonists on All-Cause Mortality in Critically Ill Patients With Essential Hypertension: A Retrospective Cohort Study.
    Pan JM; Guo Y; Jiang FF; Xu R; Zhang X; Cai WK; Yin SJ; Wang P; Huang YH; Zhang XS; Li YH; Cai L; He GH
    J Clin Pharmacol; 2024 Apr; ():. PubMed ID: 38659369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ranitidine Use and Incident Cancer in a Multinational Cohort.
    You SC; Seo SI; Falconer T; Yanover C; Duarte-Salles T; Seager S; Posada JD; Shah NH; Nguyen PA; Kim Y; Hsu JC; Van Zandt M; Hsu MH; Lee HL; Ko H; Shin WG; Pratt N; Park RW; Reich CG; Suchard MA; Hripcsak G; Park CH; Prieto-Alhambra D
    JAMA Netw Open; 2023 Sep; 6(9):e2333495. PubMed ID: 37725377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of Acid Suppressive Therapy With Cardiac Mortality in Heart Failure Patients.
    Yoshihisa A; Takiguchi M; Kanno Y; Sato A; Yokokawa T; Miura S; Abe S; Misaka T; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Takeishi Y
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28512114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between a four-parameter inflammatory index and all-cause mortality in critical ill patients with non-traumatic subarachnoid hemorrhage: a retrospective analysis of the MIMIC-IV database (2012-2019).
    Huang YW; Zhang Y; Li ZP; Yin XS
    Front Immunol; 2023; 14():1235266. PubMed ID: 37936706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model.
    Seo SI; You SC; Park CH; Kim TJ; Ko YS; Kim Y; Yoo JJ; Kim J; Shin WG
    J Gastroenterol Hepatol; 2020 Aug; 35(8):1325-1330. PubMed ID: 31970824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of H2-receptor antagonists.
    Iberti TJ
    DICP; 1990 Nov; 24(11 Suppl):S35-7. PubMed ID: 1980182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective effect of histamine H2 antagonists in congestive heart failure: A systematic review and meta-analysis.
    Zhang J; Cai WK; Zhang Z; Wang P; Lin XQ; Feng J; Fu SC; He GH
    Medicine (Baltimore); 2018 Apr; 97(15):e0409. PubMed ID: 29642208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment H2 receptor antagonists that differ in P450 modulation activity: comparative effects on paclitaxel clearance rates and neutropenia.
    Slichenmyer WJ; Donehower RC; Chen TL; Bowling MK; McGuire WP; Rowinsky EK
    Cancer Chemother Pharmacol; 1995; 36(3):227-32. PubMed ID: 7781143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are Proton Pump Inhibitors More Effective Than Histamine-2-Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients? A Systematic Review and Meta-Analysis of Cohort Studies.
    He N; Yan Y; Su S; Ge Q; Zhai S
    Ann Pharmacother; 2022 Sep; 56(9):988-997. PubMed ID: 34971320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of histamine H
    Adelborg K; Sundbøll J; Schmidt M; Bøtker HE; Weiss NS; Pedersen L; Sørensen HT
    Clin Epidemiol; 2018; 10():521-530. PubMed ID: 29765253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis for the repurposing of histamine H2-receptor antagonist to treat COVID-19.
    Ishola AA; Joshi T; Abdulai SI; Tijjani H; Pundir H; Chandra S
    J Biomol Struct Dyn; 2022 Aug; 40(13):5785-5802. PubMed ID: 33491579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: an updated systematic review and network meta-analysis of randomized trials.
    Wang Y; Ge L; Ye Z; Siemieniuk RA; Reintam Blaser A; Wang X; Perner A; Møller MH; Alhazzani W; Cook D; Guyatt GH
    Intensive Care Med; 2020 Nov; 46(11):1987-2000. PubMed ID: 32833040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extremely early onset of ranitidine action on human histamine H2 receptors expressed in HEK293 cells.
    Fukushima Y; Ishikawa T; Saitoh T; Tateishi K; Ogihara T; Fujishiro M; Shojima N; Honda M; Kushiyama A; Anai M; Sakoda H; Ono H; Onishi Y; Otsuka H; Katagiri H; Nagai R; Omata M; Asano T
    Digestion; 2003; 68(2-3):145-52. PubMed ID: 14671421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Cancer in Association with Ranitidine and Nizatidine vs Other H2 Blockers: Analysis of the Japan Medical Data Center Claims Database 2005-2018.
    Iwagami M; Kumazawa R; Miyamoto Y; Ito Y; Ishimaru M; Morita K; Hamada S; Tamiya N; Yasunaga H
    Drug Saf; 2021 Mar; 44(3):361-371. PubMed ID: 33247391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton Pump Inhibitors Versus Histamine-2 Receptor Antagonists Likely Increase Mortality in Critical Care: An Updated Meta-Analysis.
    Lee TC; Goodwin Wilson M; Lawandi A; McDonald EG
    Am J Med; 2021 Mar; 134(3):e184-e188. PubMed ID: 32931766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine H
    Larson SR; Vasbinder AL; Reding KW; Leary PJ; Branch KR; Shadyab AH; Johnson KC; Haring B; Wallace R; Manson JE; Anderson G; Cheng RK
    J Am Heart Assoc; 2022 Mar; 11(5):e024270. PubMed ID: 35191329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
    Ohsawa T; Hirata W; Higichi S
    Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of H2-antagonists on histamine- or dimaprit-stimulated H2-receptors of spontaneously beating guinea-pig atrium.
    Krielaart MJ; Veenstra DM; van Buuren KJ
    Agents Actions; 1990 Aug; 31(1-2):23-35. PubMed ID: 1704683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.